End of LifePTPSNCT07191184
Identification of Obstacles and Levers to the Outpatient Care of Patients in Terminal Palliative Situations
An observational study of End of Life, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
80% of patients wish to die at home. The number of deaths will increase in the coming years due to the aging population. The general practitioner (GP) is at the center of this care. Despite national plans for the development of palliative care, dying at home remains complicated. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- End of Life
- How many people
- 12 participants
- Where
- 1 siteFrance
- Study dates
- 16 Sep 2024to 16 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: General physician based in Bas-Rhin agreeing to participate in the research
Who may be able to join
- General physician based in Bas-Rhin
- Agreeing to participate in the research
Who cannot join
- Refusing to participate in the research
- Replacement physician, specialist physician, based outside Bas-Rhin
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service de soins Palliatifs - CHU de Strasbourg - France
Strasbourg, 67091
Catherine CHEVALIER-LAMOUILLE, MD, 33 3 88 11 65 86, catherine.lamouille@chru-strasbourg.fr
Catherine CHEVALIER-LAMOUILLE, MD
About this study
Official title: Identification of Obstacles and Levers to the Outpatient Care of Patients in Terminal Palliative Situations: Exploratory Study Among General Practitioners in Bas-Rhin
80% of patients wish to die at home. The number of deaths will increase in the coming years due to the aging population. The general practitioner (GP) is at the center of this care. Despite national plans for the development of palliative care, dying at home remains complicated. The difficulties described and known are organizational (workload) and linked to the doctor's experience with the suffering of the patient and their family. Many studies have been conducted in hospital settings, and the solutions developed are often not very accessible to GP. Conducting a study on this subject will allow us to take stock of this outpatient care provided by general practitioners following numerous changes that have occurred in recent years, both in terms of palliative care teaching and in terms of modifications to the care offered.
- Conditions
- End of Life
- Keywords
- Palliative care, Terminal palliative situations
- Medical subject headings
- Death
What is being measured
The primary outcome is the main question the study is designed to answer.
Identify barriers to outpatient care for terminally ill palliative patients by general practitioners in the Bas Rhin region.
Measured: At 8 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Sep 2025
- Study start16 Sep 2024
- Primary completion16 Dec 2025 (estimated)
- Study completion16 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for End of LifeStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 12 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07191184
- Sponsor's protocol ID
- 9303
- Acronym
- PTPS
- Status last verified
- Mar 2025
- First submitted
- 27 Mar 2025
- Last updated
- 24 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Identification of Obstacles and Levers to the Outpatient Care of Patients in Terminal Palliative Situations: Exploratory Study Among General Practitioners in Bas-Rhin
- ClinicalTrials.gov ID
- NCT07191184
- Acronym / sponsor ID
- PTPS / 9303
- Conditions
- End of Life
- Keywords
- Palliative care, Terminal palliative situations
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 12 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 16 Sep 2024 (actual)
- Primary completion
- 16 Dec 2025 (estimated)
- Study completion
- 16 Dec 2025 (estimated)
- First posted
- 24 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
80% of patients wish to die at home. The number of deaths will increase in the coming years due to the aging population. The general practitioner (GP) is at the center of this care. Despite national plans for the development of palliative care, dying at home remains complicated. The difficulties described and known are organizational (workload) and linked to the doctor's experience with the suffering of the patient and their family. Many studies have been conducted in hospital settings, and the solutions developed are often not very accessible to GP. Conducting a study on this subject will allow us to take stock of this outpatient care provided by general practitioners following numerous changes that have occurred in recent years, both in terms of palliative care teaching and in terms of modifications to the care offered.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- General physician based in Bas-Rhin agreeing to participate in the research
Key inclusion criteria (2 listed)
- General physician based in Bas-Rhin
- Agreeing to participate in the research
Key exclusion criteria (2 listed)
- Refusing to participate in the research
- Replacement physician, specialist physician, based outside Bas-Rhin
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Identify barriers to outpatient care for terminally ill palliative patients by general practitioners in the Bas Rhin region.
Time frame: At 8 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Sep 2025.
Related trials for End of Life
RecruitingObservational study
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
Cardiomyopathies, Cardiac Arrest
Not yet recruiting
Miniature In-line Respirator
Brain Death, Respiration, Artificial
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of End of Life, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Catherine CHEVALIER-LAMOUILLE, MD (33 3 88 11 65 86, catherine.lamouille@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Identify barriers to outpatient care for terminally ill palliative patients by general practitioners in the Bas Rhin region. (time frame: At 8 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2025.